Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines? [1]

Human Vaccines

Volumn 3, Issue 2, 2007, Pages 39-40

  Pier, Gerald B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Conjugate; Pseudomonas aeruginosa Exotoxin A; Staphylococcus aureus; Vaccine

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL TOXIN; CARBOHYDRATE ANTIGEN; CARRIER PROTEIN; PSEUDOMONAS EXOTOXIN; PSEUDOMONAS EXOTOXIN A; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VACCINE;

CLINICAL TRIAL; CONJUGATE; HEMODIALYSIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOGENICITY; KIDNEY FAILURE; LETTER; MEDICAL LITERATURE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; VACCINATION;

EID: 33947700353     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.3.2.3715     Document Type: Letter

References (9)

1. Ho MM, Bolgiano B, Martino A, Kairo SK, Corbel MJ. Preclinical laboratory evaluation of a bivalent Staphylococcus aureus saccharide-exotoxin A protein conjugate vaccine. Hum Vaccin 2006; 2:89-98.
2. Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J, Yeoh H, Law D, Robbins JB, Schneerson R, Muenz L, Fuller S, Johnson J, Fireman B, Alcorn H, Naso R. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002; 346:491-6.
3. Fattom AI, Sarwar J, Ortiz A, Naso R. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP- specific antibodies protect mice against bacterial challenge. Infect Immun 1996; 64:1659-65.
4. Cryz Jr. SJ, Sadoff JC, Füter E. Octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. Microb Pathog 1989; 6:75-80.
5. Cryz Jr. SJ, Sadoff JC, Füter E. Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine: effect of a booster dose on antibody levels in humans. Infect Immun 1988; 56:1829-30.
6. Welch PG, Fattom A, Moore J, Jr., Schneerson R, Shiloach J, Bryla DA, Li X, Robbins JB. Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis. J Am Soc Nephrol 1996; 7:247-53.
7. Cryz Jr. SJ, Furer E, Sadoff JC, Fredeking T, Que JU, Cross AS. Production and charac-terization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species. J Infect Dis 1991; 163:1055-61.
8. Donta ST, Peduzzi P, Cross AS, Sadoff J, Haakenson C, Cryz SJ, Kauffman C, Bradley S, Gafford G, Elliston D, Beam TR, John JF, Ribner B, Cantey R, Welsh CH, Ellison RT, Young EJ, Hamill RJ, Leaf H, Schein RMH, Mulligan M, Johnson C, Abrutyn E, Griffiss JM, Hamadeh R, Eliasson AH, Mcclain JB, Melcher GP, Kelly JW Byrne WR, Wallace M, Amundson D, Gumpert B, Slagle D. Immunoprophylaxis against Klebsiella and Pseudomonas aeruginosa infections. J Infect Dis 1996; 174:537-43.
9. Zuercher AW, Horn MP, Que JU, Ruedeberg A, Schoeni MH, Schaad UB, Marcus P, Lang AB. Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis. FEMS Immunol Med Microbiol 2006; 47:302-8.